Search Results - "Pongas, Georgios"

Refine Results
  1. 1

    PI3K Signaling Pathway in Normal B Cells and Indolent B Cell Malignancies by Pongas, Georgios, M.D, Cheson, Bruce D., M.D

    Published in Seminars in oncology (01-12-2016)
    “…In chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphomas (NHL), B cell receptor signaling leads to activation of the PI3K pathway. Idelalisib, a PI3Kδ…”
    Get full text
    Journal Article
  2. 2

    Successful treatment of a CLL associated IgM hyper-viscosity syndrome: A rare case by Tannous, Toufic, Hevroni, Gil, Islam, Raiyan, Pongas, Georgios

    Published in Leukemia research reports (2024)
    “…In the context of chronic lymphocytic leukemia (CLL), Hyperviscosity Syndrome (HVS) typically arises from hyperleukocytosis, although it infrequently stems…”
    Get full text
    Journal Article
  3. 3

    PI3Kδ inhibition causes feedback activation of PI3Kα in the ABC subtype of diffuse large B-cell lymphoma by Pongas, Georgios N, Annunziata, Christina M, Staudt, Louis M

    Published in Oncotarget (10-10-2017)
    “…Cell line models of the activated B cell-like (ABC) subtype of diffuse large B cell (DLBCL) depend on both NF-κB and phosphatidylinositol 3-kinase (PI3K)…”
    Get full text
    Journal Article
  4. 4

    HIV-Associated Lymphomas: Progress and New Challenges by Pongas, Georgios N, Ramos, Juan C

    Published in Journal of clinical medicine (07-03-2022)
    “…The association of human immunodeficiency virus (HIV) and aggressive lymphomas was first reported in 1982. Before the development of effective HIV antiviral…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Mantle cell lymphoma involving the thyroid gland by Pongas, Georgios N, Alderuccio, Juan Pablo, Chapman, Jennifer R., Lossos, Izidore S

    Published in Clinical case reports (01-09-2021)
    “…Mantle cell lymphoma (MCL) rarely involves thyroid gland. Positron emission tomography–computed tomography (PET‐CT) may be critical in identifying thyroid…”
    Get full text
    Journal Article
  7. 7

    Activity of Deferasirox in Mucorales: Influences of Species and Exogenous Iron by LEWIS, Russell E, PONGAS, Georgios N, ALBERT, Nathaniel, BEN-AMI, Ronen, WALSH, Thomas J, KONTOYIANNIS, Dimitrios P

    Published in Antimicrobial Agents and Chemotherapy (01-01-2011)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    BEZ235: When Promising Science Meets Clinical Reality by Pongas, Georgios, Fojo, Tito

    Published in The oncologist (Dayton, Ohio) (01-09-2016)
    “…An article in a recent issue of The Oncologist reports the results of a phase I clinical trial of BEZ235 in patients with advanced renal cell carcinoma. The…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Outcomes of Richter’s syndrome in patients with chronic lymphocytic leukemia (CLL) treated with platinum or anthracycline based chemotherapy with or without a BTK inhibitor (BTKi) by Alasfour, Maryam, Pongas, Georgios, Jones, Sandra, Alawadi, Salman, Plate, Thomas

    Published in Journal of clinical oncology (01-06-2022)
    “…e19511 Background: Richter’s syndrome (RS) is a rare complication of chronic lymphocytic leukemia (CLL) and the median survival is generally poor. Evidence is…”
    Get full text
    Journal Article
  13. 13

    Recent Advances in the Management of Patients with Relapsed/Refractory Follicular Lymphoma by Pongas, Georgios, Cheson, Bruce

    Published in Blood and lymphatic cancer (31-07-2021)
    “…Advanced follicular lymphoma (FL) often relapses after front-line chemoimmunotherapy, and many patients will eventually require subsequent therapy. In 2021,…”
    Get full text
    Journal Article
  14. 14

    Outcomes in peripheral T-cell lymphomas: An analysis of patients treated at a single academic institution by Costa, Philippos Apolinario, Ocejo Gallegos, Jesus Antonio, Pongas, Georgios

    Published in Journal of clinical oncology (20-05-2021)
    “…Abstract only e19524 Background: T-cell lymphomas are a heterogeneous group of lymphomas, including the cutaneous T cell lymphoma (CTCL) and the peripheral T…”
    Get full text
    Journal Article
  15. 15

    Innovations in Antibody-Drug Conjugate (ADC) in the Treatment of Lymphoma by Al Sbihi, Ali, Alasfour, Maryam, Pongas, Georgios

    Published in Cancers (01-02-2024)
    “…Chemoimmunotherapy and cellular therapy are the mainstay of the treatment of relapsed/refractory (R/R) lymphomas. Development of resistance and commonly…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19

    Advances in Targeted Therapy: Addressing Resistance to BTK Inhibition in B-Cell Lymphoid Malignancies by Bravo-Gonzalez, Andres, Alasfour, Maryam, Soong, Deborah, Noy, Jose, Pongas, Georgios

    Published in Cancers (10-10-2024)
    “…B-cell lymphoid malignancies are a heterogeneous group of hematologic cancers, where Bruton's tyrosine kinase (BTK) inhibitors have received FDA approval for…”
    Get full text
    Journal Article
  20. 20